Results 241 to 250 of about 88,910 (264)
Epilepsy as a dynamic disease: Toward actionable, individualized seizure risk prediction
Abstract The current definition of epilepsy allows diagnosis after a single unprovoked seizure if the estimated 10‐year recurrence risk is ≥60%. While this framework is grounded in epidemiological evidence, it does not align with the shorter time horizons that guide many clinical and personal decisions.
Kai Michael Schubert +3 more
wiley +1 more source
Abstract Objective Acute symptomatic seizures (ASyS) occur in up to 30% of patients with intracerebral hemorrhage (ICH) when continuous electroencephalography (cEEG) is used, potentially worsening outcomes. Identification of early EEG biomarkers of ASyS may help guide personalized antiseizure medication (ASM) prophylaxis.
Ziad Al‐Fatuhi‐Al‐Jundi +20 more
wiley +1 more source
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations. [PDF]
Fan B, Zhao JV.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cancer epigenetics in clinical practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly
Modern developments in germline pharmacogenomics for oncology prescribing
Ca-A Cancer Journal for Clinicians, 2022Natalie M Reizine, Peter H O'donnell
exaly
Nanooncology: The future of cancer diagnosis and therapy
Ca-A Cancer Journal for Clinicians, 2013Sanjiv S Gambhir
exaly
Application of Nanotechnology in Cancer Therapy and Imaging
Ca-A Cancer Journal for Clinicians, 2008Dong M Shin
exaly
Recent developments in esophageal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2013Jesper Lagergren, Pernilla Lagergren
exaly

